Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.75 | N/A |
| PEG Ratio (TTM) | -15.96 | N/A |
| P/S Ratio (TTM) | 0.68 | N/A |
| P/B Ratio (TTM) | 1.35 | N/A |
| P/FCF Ratio (TTM) | 20.52 | N/A |
| Price to 5YR AVG Earnings Ratio | 21.30 | N/A |
| Price to 5YR AVG FCF Ratio | 11.34 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.54% | N/A |
| ROE (TTM) | 11.59% | N/A |
| Net Profit Margin (TTM) | 5.90% | N/A |
| ROIC 5YR AVG | 4.16% | N/A |
Growth (32%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.59% | -58.86% | 53.06% |
| Revenue | -0.92% | 4.16% | 2.63% |
| Net Income | 0.05% | -59.16% | 52.37% |
| Cash Flow | -25.20% | -35.13% | 123.34% |
Health (68%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.93 | N/A |
| Quick Ratio (TTM) | 1.05 | N/A |
| D/E Ratio (TTM) | 0.45 | N/A |
| Interest Coverage (TTM) | 18.20 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 3.09 | N/A |
| LTL to 5YR AVG FCF | 4.46 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.21% | N/A |